Why Reinsurance Group of America is on investors’ radar today
Reinsurance Group of America (RGA) has drawn fresh attention after recent trading left the shares around $206.85, with mixed short term returns and a longer track record that some investors are reassessing.
See our latest analysis for Reinsurance Group of America.
At a share price of $206.85, RGA has eased back recently, with a 30 day share price return of an 8.21% decline. Its 1 year total shareholder return of 12.51% and 5 year total shareholder return of 77.10% keep the longer term picture in focus, suggesting that recent weakness may reflect shifting risk perceptions rather than a clear break in the broader trend.
If this kind of reinsurance story has you thinking about where else risk and reward meet, now could be a good moment to check out 20 top founder-led companies as another source of ideas.
With RGA trading at $206.85, a value score of 5, an intrinsic discount of 71.65% and a 20.65% discount to the average analyst price target, the question becomes whether there is mispricing or whether the market is already incorporating expectations about future growth.
Most Popular Narrative: 29.9% Undervalued
With Reinsurance Group of America last closing at $206.85 against a narrative fair value of $295.00, the current price sits well below that narrative anchor, putting the focus squarely on what kind of growth and profitability profile would support that gap.
RGA's continuously improving digital platform and advanced analytics are beginning to generate operating leverage and superior risk selection, with early results indicating the potential to structurally elevate net margins; as these innovations compound, RGA is positioned to outperform on profitability, supporting outsized long-term earnings growth.
Curious what earnings power justifies that higher fair value? The narrative leans on faster top line expansion, fatter margins, and a future earnings multiple that looks very different from today. The exact mix of those levers might surprise you.
Result: Fair Value of $295.00 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, that upbeat story can wobble if claims volatility persists, or if competitive pressure and changing demographics curb demand for RGA's core life and health reinsurance products.
Find out about the key risks to this Reinsurance Group of America narrative.
Another View: What Earnings Ratios Are Saying
So far, the story leans on fair value estimates and future growth, but the current P/E of 11.5x tells a slightly different story. It sits a touch above the peer average of 10.4x, yet sits below a fair ratio of 15.9x that the market could eventually lean toward.
For you, that mix means the shares are not screamingly cheap or stretched on today’s earnings. At the same time, the gap to the fair ratio hints at both upside potential and the risk that expectations need to keep holding up. Which side of that trade off do you think is more likely to play out?
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
If this all sounds cautiously optimistic, it is worth checking the numbers yourself sooner rather than later and stress testing your own assumptions; to help with that, take a closer look at the 5 key rewards that investors are currently focused on.
Looking for more investment ideas?
If you stop at one company, you could miss stronger opportunities, so make time today to scan a few focused lists and pressure test your next moves.
- Start building a watchlist of firms that look cheap on quality and fundamentals by reviewing our 48 high quality undervalued stocks.
- Strengthen the defensive side of your portfolio by checking companies highlighted in our 68 resilient stocks with low risk scores.
- Spot early stage opportunities with solid numbers by browsing our screener containing 23 high quality undiscovered gems before others catch on.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com